Alex Toker
From Wikipedia, the free encyclopedia
Alex Toker is currently a professor at the Department of Pathology at Beth Israel Deaconess Medical Center, Harvard Medical School and Chief of the Division of Signal Transduction and Associate Director of the Cancer Research Institute in the Cancer Center.[1][2] Toker is an expert in the signaling mechanisms that govern cancer progression.[3] His research focus on understanding mechanism of cancer including tumor cell survival, invasion and metastasis. He is currently editor-in-chief of the Journal of Biological Chemistry.[4][5]
This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. (October 2021) |
Quick Facts Prof. Alex Toker, Alma mater ...
Prof. Alex Toker | |
---|---|
Alma mater | |
Scientific career | |
Fields | Biology, cell biology, apoptosis, Cancer |
Institutions | |
Close
In 2022 Toker was the recipient of the Avanti Award in Lipids.[6]